194 related articles for article (PubMed ID: 33081534)
1. Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.
Gohil VM
Expert Opin Investig Drugs; 2021 Jan; 30(1):1-4. PubMed ID: 33081534
[No Abstract] [Full Text] [Related]
2. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice.
Guthrie LM; Soma S; Yuan S; Silva A; Zulkifli M; Snavely TC; Greene HF; Nunez E; Lynch B; De Ville C; Shanbhag V; Lopez FR; Acharya A; Petris MJ; Kim BE; Gohil VM; Sacchettini JC
Science; 2020 May; 368(6491):620-625. PubMed ID: 32381719
[TBL] [Abstract][Full Text] [Related]
3. Elesclomol restores mitochondrial function in genetic models of copper deficiency.
Soma S; Latimer AJ; Chun H; Vicary AC; Timbalia SA; Boulet A; Rahn JJ; Chan SSL; Leary SC; Kim BE; Gitlin JD; Gohil VM
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8161-8166. PubMed ID: 30038027
[TBL] [Abstract][Full Text] [Related]
4. Copper histidinate therapy in Menkes' disease: prevention of progressive neurodegeneration.
Sherwood G; Sarkar B; Kortsak AS
J Inherit Metab Dis; 1989; 12 Suppl 2():393-6. PubMed ID: 2512453
[No Abstract] [Full Text] [Related]
5. Vitamin C treatment in Menkes' disease: failure to affect biochemical and clinical parameters.
de Groot CJ; Wijburg FA; Barth PG; Bolhuis PA; Peelen W; Abeling NG; van den Hamer CJ
J Inherit Metab Dis; 1989; 12 Suppl 2():389-92. PubMed ID: 2512452
[No Abstract] [Full Text] [Related]
6. The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug.
Ngwane AH; Petersen RD; Baker B; Wiid I; Wong HN; Haynes RK
IUBMB Life; 2019 May; 71(5):532-538. PubMed ID: 30698324
[TBL] [Abstract][Full Text] [Related]
7. The failure of parenteral copper therapy in Menkes Kinky Hair syndrome.
Garnica AD
Eur J Pediatr; 1984 Jun; 142(2):98-102. PubMed ID: 6468439
[TBL] [Abstract][Full Text] [Related]
8. Menkes kinky hair syndrome: Is it a treatable disorder?
Garnica AD; Frias JL; Rennert OM
Clin Genet; 1977 Feb; 11(2):154-61. PubMed ID: 189959
[TBL] [Abstract][Full Text] [Related]
9. Life-span and Menkes kinky hair syndrome: report of a 13-year course of this disease.
Sander C; Niederhoff H; Horn N
Clin Genet; 1988 Mar; 33(3):228-33. PubMed ID: 3359680
[TBL] [Abstract][Full Text] [Related]
10. Menkes' Kinky hair syndrome: studies of copper metabolism and long term copper therapy.
Williams DM; Atkin CL; Frens DB; Bray PF
Pediatr Res; 1977 Jul; 11(7):823-6. PubMed ID: 876703
[TBL] [Abstract][Full Text] [Related]
11. [Copper metabolism and genetic disorders].
Shimizu N
Nihon Rinsho; 2016 Jul; 74(7):1151-5. PubMed ID: 27455805
[TBL] [Abstract][Full Text] [Related]
12. Copper deficiency in the mitochondria of cultured skin fibroblasts from patients with Menkes syndrome.
Kodama H; Okabe I; Yanagisawa M; Kodama Y
J Inherit Metab Dis; 1989; 12(4):386-9. PubMed ID: 2560098
[TBL] [Abstract][Full Text] [Related]
13. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells.
Nagai M; Vo NH; Shin Ogawa L; Chimmanamada D; Inoue T; Chu J; Beaudette-Zlatanova BC; Lu R; Blackman RK; Barsoum J; Koya K; Wada Y
Free Radic Biol Med; 2012 May; 52(10):2142-50. PubMed ID: 22542443
[TBL] [Abstract][Full Text] [Related]
14. Renal function in patients with Menkes disease.
Ozawa H; Kodama H; Kawaguchi H; Mochizuki T; Kobayashi M; Igarashi T
Eur J Pediatr; 2003 Jan; 162(1):51-2. PubMed ID: 12607531
[No Abstract] [Full Text] [Related]
15. Early copper-histidine treatment for Menkes disease.
Tümer Z; Horn N; Tønnesen T; Christodoulou J; Clarke JT; Sarkar B
Nat Genet; 1996 Jan; 12(1):11-3. PubMed ID: 8528242
[No Abstract] [Full Text] [Related]
16. [Manufacturing and stability of copper-histidine solution for treatment of Menkes' Kinky Hair Syndrome].
Hoppe-Tichy T; Nguyen TH; Hentze BW; Lorke M
Pharmazie; 2005 Mar; 60(3):205-7. PubMed ID: 15801674
[TBL] [Abstract][Full Text] [Related]
17. Inborn errors of copper metabolism: kinky hair disease and hepatolenticular degeneration. Therapeutic approaches.
Dekaban AS
Mater Med Pol; 1976; 8(2):167-72. PubMed ID: 979354
[No Abstract] [Full Text] [Related]
18. Recent developments in Menkes disease.
Kodama H
J Inherit Metab Dis; 1993; 16(4):791-9. PubMed ID: 8412022
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics and pathophysiology of Menkes disease.
Kodama H; Murata Y
Pediatr Int; 1999 Aug; 41(4):430-5. PubMed ID: 10453200
[TBL] [Abstract][Full Text] [Related]
20. A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase.
Kim BE; Smith K; Petris MJ
J Med Genet; 2003 Apr; 40(4):290-5. PubMed ID: 12676902
[No Abstract] [Full Text] [Related]
[Next] [New Search]
